These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1685992)

  • 1. The effect of urapidil on responses to phenylephrine, angiotensin and isoprenaline in man.
    Tomlinson B; Renondin JC; Graham BR; Prichard BN
    Eur J Clin Pharmacol; 1991; 41(1):1-3. PubMed ID: 1685992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha adrenergic blocking activity of urapidil in man.
    Jamieson MJ; Shepherd AM; Jackson SH; Patel SS; Flanagan PH; Galbraith H
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):173-85. PubMed ID: 2908008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of adrenoceptor blockade and hypotension elicited by urapidil and prazosin in conscious rat.
    Goering J; Zimmerman BG
    J Pharmacol Exp Ther; 1986 May; 237(2):553-7. PubMed ID: 2871176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of reflex tachycardia following alpha-adrenoceptor blockade in conscious dogs: comparison of urapidil with prazosin.
    Shebuski RJ; Zimmerman BG
    J Cardiovasc Pharmacol; 1984; 6(5):788-94. PubMed ID: 6209481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
    Kolassa N; Beller KD; Sanders KH
    Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK; Kellar KJ; Gillis RA
    J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of urapidil on alpha- and beta-adrenoreceptors in pithed rats.
    Sanders KH; Kilian U; Kolassa N; Schoetensack W
    J Auton Pharmacol; 1985 Dec; 5(4):307-16. PubMed ID: 3005330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of urapidil on beta-adrenoceptors of rat atria.
    Verberne AJ; Rand MJ
    Eur J Pharmacol; 1985 Jan; 108(2):193-6. PubMed ID: 2984023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of the beta-blocking activity of urapidil: a new method.
    Jamieson MJ; Jackson SH; Patel SS; Shepherd AM; Galbraith H; Stewart W; Flanagan PH
    Eur J Clin Pharmacol; 1986; 31(2):149-54. PubMed ID: 2879734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
    Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of urapidil on cardiac alpha- and beta-adrenoceptors.
    Schümann HJ; Bielefeld FW
    Arzneimittelforschung; 1986 Oct; 36(10):1471-6. PubMed ID: 3028433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of urapidil.
    Prichard BN; Renondin JC; Tomlinson B
    J Hypertens Suppl; 1988 Dec; 6(2):S13-9. PubMed ID: 2906695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimazosin: relationships between hypotensive effect, vascular responsiveness, and drug and metabolite concentrations.
    Vincent J; Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1985; 7(5):913-8. PubMed ID: 2413300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional haemodynamic effects of urapidil in conscious dogs with chronic coronary artery occlusion.
    Wouters PF; Marcus MA; Van Aken HK; van de Velde M; Miserez M; Deruyter HA; Mignolet K; Flameng W
    Eur J Anaesthesiol; 1994 Sep; 11(5):381-90. PubMed ID: 7988582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of urapidil, prazosin, and clonidine on ligand binding to central nervous system receptors, arterial pressure, and heart rate in experimental animals.
    Kellar KJ; Quest JA; Spera AC; Buller A; Conforti A; Dias Souza J; Gillis RA
    Am J Med; 1984 Oct; 77(4A):87-95. PubMed ID: 6091452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The central and peripheral components in the mechanism of action of urapidil].
    Maĭorov DN; Medvedev OS
    Eksp Klin Farmakol; 1992; 55(1):31-3. PubMed ID: 1305430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urapidil, a multiple-action alpha-blocking drug.
    Prichard BN; Tomlinson B; Renondin JC
    Am J Cardiol; 1989 Aug; 64(7):11D-15D. PubMed ID: 2569263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.